Lower risk Drug recall · FDA · Published August 24, 2026

ImprimisRx Povidone Iodine Ophthalmic Solution Recall: Subpotent Drug Risk

ImprimisRx recalls 10mL ophthalmic solution with subpotent drug risk. This may not work as intended for eye procedures. Check NDC 71384-732-10 and lot numbers for affected products.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0835-2026Drug ImprimisRx ›

Lower-risk recall

Subpotent Drug

✎ GovInfoNow plain-language explainer

ImprimisRx is recalling ophthalmic solution that may not contain enough active ingredients. This could lead to ineffective treatment during eye procedures if used without proper concentration. Read more at govinfonow.com/recall/1004689-imprimisrx-povidone-iodine-ophthalmic-solution-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/1004689-imprimisrx-povidone-iodine-ophthalmic-solution-recall-subpotent-drug-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0835-2026

Cite this page

“ImprimisRx Povidone Iodine Ophthalmic Solution Recall: Subpotent Drug Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1004689-imprimisrx-povidone-iodine-ophthalmic-solution-recall-subpotent-drug-risk. Based on FDA recall #D-0835-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0835-2026%22&limit=1).

ImprimisRx NJ LLC voluntarily recalled Povidone Iodine / Proparacaine HCl Ophthalmic Solution due to subpotent drug risks, the FDA announced on Aug. 24, 2026. Owners should contact the company for a refund.

How to tell if you have it

Brand: ImprimisRx
Product: Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle
NDC: 71384-732-10
Lot codes: 26JAN035 (BUD 09/07/2026), 26FEB015 (BUD 09/24/2026)
Distribution: USA Nationwide

The hazard

The recall addresses the risk of subpotent drug, meaning the medication may not provide the expected therapeutic effect. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show ImprimisRx issued a Tri-Moxi+ Intraocular Injection recall on Dec. 18, 2025, citing glass particles risk. Other recent recalls of similar products include the Klarity-C Drops recall (Oct. 20, 2025) for subpotent drug risk and the Imprimis Dexamethasone Moxifloxacin Eye Drops recall (Dec. 18, 2025) for glass particles hazard.

How to tell if you have this one

Check for the NDC code 71384-732-10 on the bottle. Look for lot numbers 26JAN035 (expires 09/07/2026) or 26FEB015 (expires 09/24/2026).

Brand
ImprimisRx
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Verify the NDC code 71384-732-10 and lot numbers 26JAN035 or 26FEB015 on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 23 days after the firm started it.

Aug 24, 2026Firm started the recall
Sep 8, 2026FDA classified it Class III
Sep 16, 2026Published in FDA’s Enforcement Report
Sep 23, 2026Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/1004689-imprimisrx-povidone-iodine-ophthalmic-solution-recall-subpotent-drug-risk">ImprimisRx Povidone Iodine Ophthalmic Solution Recall: Subpotent Drug Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0835-2026 (August 24, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0835-2026 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.